Management of radiation therapy-induced mucositis in head and neck cancer patients. Part II: supportive treatments

Oropharyngeal mucositis is the acute inflammatory and ulcerative reaction of the oral mucosa following radiation therapy to the head and neck region. It is such a common problem that nearly all head and neck cancer patients develop some degree of mucositis. This complication is usually transient in...

Full description

Bibliographic Details
Main Authors: Wei Cheong Ngeow, Wen Lin Chai, Rosnah Binti Zain
Format: Article
Language:English
Published: PAGEPress Publications 2011-12-01
Series:Oncology Reviews
Subjects:
Online Access:http://www.oncologyreviews.org/index.php/or/article/view/124
id doaj-04b2327d902d4cc68d90bc4c47fc750e
record_format Article
spelling doaj-04b2327d902d4cc68d90bc4c47fc750e2020-11-25T03:40:39ZengPAGEPress PublicationsOncology Reviews1970-55571970-55652011-12-012310.4081/oncol.2008.164118Management of radiation therapy-induced mucositis in head and neck cancer patients. Part II: supportive treatmentsWei Cheong Ngeow0Wen Lin Chai1Rosnah Binti Zain2Department of Oral & Maxillofacial Surgery Faculty of Dentistry, University of Malaya Kuala LumpurDepartment of General Dental Practice and Oral & Maxillofacial Imaging, Faculty of Dentistry, University of Malaya,Kuala LumpurDepartment of Oral Pathology, Oral Medicine and Periodontology Faculty of Dentistry, University of Malaya, Kuala LumpurOropharyngeal mucositis is the acute inflammatory and ulcerative reaction of the oral mucosa following radiation therapy to the head and neck region. It is such a common problem that nearly all head and neck cancer patients develop some degree of mucositis. This complication is usually transient in nature but it also represents an important clinical problem as it is a painful, debilitating, dose-dependent side effect for which there is no widely acceptable prophylaxis or effective treatment. As several authoritative groups have recently either undertaken systematic reviews or issued guidelines on the management of mucositis, it is the aim of this review instead, to provide an overview of all the remedies and pharmaceutical agents available, as well as highlighting to researchers the gaps that need to be filled.http://www.oncologyreviews.org/index.php/or/article/view/124Head and Neck Cancer - Radiation Therapy - Mucositis - Management - Pharmaceutical Agents
collection DOAJ
language English
format Article
sources DOAJ
author Wei Cheong Ngeow
Wen Lin Chai
Rosnah Binti Zain
spellingShingle Wei Cheong Ngeow
Wen Lin Chai
Rosnah Binti Zain
Management of radiation therapy-induced mucositis in head and neck cancer patients. Part II: supportive treatments
Oncology Reviews
Head and Neck Cancer - Radiation Therapy - Mucositis - Management - Pharmaceutical Agents
author_facet Wei Cheong Ngeow
Wen Lin Chai
Rosnah Binti Zain
author_sort Wei Cheong Ngeow
title Management of radiation therapy-induced mucositis in head and neck cancer patients. Part II: supportive treatments
title_short Management of radiation therapy-induced mucositis in head and neck cancer patients. Part II: supportive treatments
title_full Management of radiation therapy-induced mucositis in head and neck cancer patients. Part II: supportive treatments
title_fullStr Management of radiation therapy-induced mucositis in head and neck cancer patients. Part II: supportive treatments
title_full_unstemmed Management of radiation therapy-induced mucositis in head and neck cancer patients. Part II: supportive treatments
title_sort management of radiation therapy-induced mucositis in head and neck cancer patients. part ii: supportive treatments
publisher PAGEPress Publications
series Oncology Reviews
issn 1970-5557
1970-5565
publishDate 2011-12-01
description Oropharyngeal mucositis is the acute inflammatory and ulcerative reaction of the oral mucosa following radiation therapy to the head and neck region. It is such a common problem that nearly all head and neck cancer patients develop some degree of mucositis. This complication is usually transient in nature but it also represents an important clinical problem as it is a painful, debilitating, dose-dependent side effect for which there is no widely acceptable prophylaxis or effective treatment. As several authoritative groups have recently either undertaken systematic reviews or issued guidelines on the management of mucositis, it is the aim of this review instead, to provide an overview of all the remedies and pharmaceutical agents available, as well as highlighting to researchers the gaps that need to be filled.
topic Head and Neck Cancer - Radiation Therapy - Mucositis - Management - Pharmaceutical Agents
url http://www.oncologyreviews.org/index.php/or/article/view/124
work_keys_str_mv AT weicheongngeow managementofradiationtherapyinducedmucositisinheadandneckcancerpatientspartiisupportivetreatments
AT wenlinchai managementofradiationtherapyinducedmucositisinheadandneckcancerpatientspartiisupportivetreatments
AT rosnahbintizain managementofradiationtherapyinducedmucositisinheadandneckcancerpatientspartiisupportivetreatments
_version_ 1724533656399118336